Restoring Trust: The Need for Precision Medicine in Infectious Diseases, Public Health and Vaccines.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
01 08 2023
Historique:
medline: 23 10 2023
pubmed: 19 7 2023
entrez: 19 7 2023
Statut: ppublish

Résumé

There are limited data on precision medicine in infectious diseases and vaccines; however, precise management of infectious diseases plays a critical role in trust for government, health-care organizations, science, and pharma. The improvement in biomedical technologies, availability of large clinical and -omic data and appropriate application of artificial intelligence may allow precision in vaccines and public health and restore trust. This is an invited editorial on the role of precision medicine in infectious diseases and vaccines.

Identifiants

pubmed: 37465958
doi: 10.1080/21645515.2023.2234787
pmc: PMC10361134
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2234787

Références

J Hum Genet. 2020 Dec;65(12):1075-1082
pubmed: 32699345
Vaccine. 2013 Jun 26;31(30):3065-71
pubmed: 23664999
Am J Prev Med. 2016 Mar;50(3):398-401
pubmed: 26547538
J Prev Med Hyg. 2023 Jan 13;63(3 Suppl 2):E1-E29
pubmed: 36818497
Vaccine. 2018 Aug 6;36(32 Pt A):4761-4767
pubmed: 29580641
Vaccine. 2019 Jun 6;37(26):3419-3425
pubmed: 31097351
Int J Infect Dis. 2021 Dec;113 Suppl 1:S7-S12
pubmed: 33716195
Hum Vaccin Immunother. 2013 Jul;9(7):1466-76
pubmed: 23571167
Eur J Clin Invest. 2020 Oct;50(10):e13362
pubmed: 32726868
JAMA Intern Med. 2022 Feb 1;182(2):153-162
pubmed: 34962505
J Prev Med Hyg. 2022 Oct 27;63(3):E399-E404
pubmed: 36415293
Vaccine. 2020 Aug 27;38(38):6047-6056
pubmed: 32600916
J Infect Dis. 2010 Dec 15;202(12):1789-99
pubmed: 21067372
N Engl J Med. 2014 Mar 13;370(11):985-8
pubmed: 24520936
Immunity. 2010 Oct 29;33(4):516-29
pubmed: 21029962
Nat Immunol. 2022 Dec;23(12):1788-1798
pubmed: 36316475
BMC Public Health. 2022 Jun 4;22(1):1124
pubmed: 35659285
Front Immunol. 2020 Oct 15;11:590373
pubmed: 33178222
J Pers Med. 2021 Feb 16;11(2):
pubmed: 33669364
Gene. 2020 Oct 20;758:144944
pubmed: 32628976
J Infect Dis. 2023 Feb 1;227(3):381-390
pubmed: 35199825
Lancet Glob Health. 2020 Aug;8(8):e1003-e1017
pubmed: 32553130
Sci Rep. 2021 Apr 26;11(1):8953
pubmed: 33903695
J Int Med Res. 2021 Aug;49(8):3000605211034656
pubmed: 34382466
Nat Immunol. 2022 Dec;23(12):1777-1787
pubmed: 36316476
Vox Sang. 2021 Feb;116(2):249-250
pubmed: 32950039
World J Hepatol. 2015 Oct 28;7(24):2503-9
pubmed: 26523203
Vaccine. 2020 Feb 18;38(8):1869-1880
pubmed: 31987690
PLoS Pathog. 2011 Dec;7(12):e1002344
pubmed: 22241978
Am J Epidemiol. 2018 Dec 1;187(12):2561-2567
pubmed: 30202996
JAMA. 2019 Jan 1;321(1):31-32
pubmed: 30535130
One Health. 2019 Jan 09;7:100080
pubmed: 30671528
N Engl J Med. 2020 Oct 29;383(18):1701-1703
pubmed: 32846056
N Engl J Med. 2022 Jun 30;386(26):2531-2532
pubmed: 35704429
Crit Care Med. 2010 Apr;38(4 Suppl):e10-20
pubmed: 20048675
Semin Nephrol. 2015 May;35(3):209-11
pubmed: 26215858
J Gen Intern Med. 2002 Jan;17(1):79-81
pubmed: 11903779
Lancet Glob Health. 2020 Feb;8(2):e180-e190
pubmed: 31862245
Cell. 2020 Oct 29;183(3):837
pubmed: 33125895
Int J Equity Health. 2021 Nov 24;20(1):248
pubmed: 34819081

Auteurs

Ozlem Equils (O)

Public Health Non-Profit, MiOra, Los Angeles, CA, USA.
Clinical Development, Cidara Therapeutics, San Diego, CA, USA.

Angela Bakaj (A)

Public Health Non-Profit, MiOra, Los Angeles, CA, USA.

Brittany Wilson-Mifsud (B)

Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

Archana Chatterjee (A)

Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH